The global automated nucleic acid extraction systems market is set to expand at a robust compound annual growth rate (CAGR) of 10.9% between 2022 and 2032, according to a recent report by Future Market Insights. This growth is driven by the increasing adoption of nucleic acid extraction systems, which play a critical role in nucleic acid purification, personalized medicine, and predictive healthcare solutions.
Nucleic acid extraction systems are gaining popularity due to their ability to efficiently and accurately extract DNA and RNA, which are essential in a variety of research and diagnostic applications, including genomics, molecular diagnostics, and biotechnology. As the demand for personalized medicine continues to rise, these systems are becoming an integral part of healthcare innovations aimed at providing more precise and tailored treatments.
Key Market Drivers:
- Precision Medicine Boom: The growing shift towards personalized and predictive medicine is boosting demand for efficient nucleic acid extraction technologies.
- Improved Diagnostic Efficiency: Automated nucleic acid extraction systems are recognized for their ability to streamline the process of DNA and RNA purification, ensuring high-quality samples for research and clinical applications.
- Rising Biotechnology and Genomics Applications: These systems are widely used in research labs, biotechnology firms, and hospitals, making them indispensable for disease diagnosis, genetic studies, and drug development.
The report suggests that the rising interest in genomic research and advancements in molecular diagnostics will continue to propel the market forward. Additionally, the role of nucleic acid extraction systems in ensuring the success of predictive medicine highlights their increasing significance in shaping the future of healthcare.
These systems are designed in such a way that they efficiently run multiple processes at the same time with a reduced error ratio thereby acting as a major driver in the automated nucleic acid extraction systems market. Furthermore, the rising utilization of automotive procedures in research and development has bolstered the demand for technologically superior automatic nucleic acid extraction systems.
Key Takeaways
- The isolation and the purification in the automated nucleic acid extraction systems fall under the category of fundamental tests in molecular laboratory research which further comprises a vast range of equipment and procedures available for its extraction.
- Furthermore, user-friendly interfaces are integrated with the systems to further simplify the processes. Moreover, the functionality of these systems comprises shaking, temperature control, and PCR protocols.
- Automated nucleic acid extraction systems also help in minimizing the contamination in samples, providing high throughput results in comparatively lesser time and reducing the reagent wastage. Owing to these factors, the global demand for automated nucleic acid extraction systems is on the rise.
- These systems are vastly employed in molecular biology, pathology, forensic science, environmental research, and drug delivery. Furthermore, these automated systems are known for their advancements in order to extract nucleic acid from a variety of samples such as tissue, cell culture, whole blood, serum, plasma, swab, etc.
- The nucleic acid extraction system market is predicted to rise steadily as these user–friendly methods reduce sample contamination, provide high throughput results at a rapid pace, and greatly reduce reagent wastage.
- Surging laboratory automation and widespread adoption of superior technology for faster and better results propels market growth. Furthermore, technological advancements in automated nucleic acid extraction systems in improving the workflow and decreasing variability also support the automated nucleic acid extraction systems market.
- The high cost of the system, limited product acceptability, high maintenance, system complexity, and service cost are some of the limiting factors restricting potential market growth. In addition to that, low market penetration of automated systems in less developed regions also restricts global market growth.
Competitive Landscape
Some of the prominent players in the global automated nucleic acid extraction systems market are focusing on technological advancements in order to attain an edge over the market. Various other regional players are concentrating on collaboration to efficiently cater to the ever-increasing customer demands.
A large number of companies are involved in the rapid manufacturing of such laboratory instruments varying by size, usage, capacity, price, and versatility. These days, most commercial extraction kits are also available in the market-based in line with automated nucleic acid extraction platforms. Continuous enhancements for the system updating also help in proliferating the market growth for nucleic acid extraction systems.
Several other companies are rapidly adopting strategies for building their networks and strengthening their sales force to increase their product sales. Furthermore, brand value is also considered a vital parameter affecting the sales of a certain company. New product development, mergers, acquisitions, and partnerships are some of the key trends in the automated nucleic acid extraction systems market.
Key Players:
- Qiagen N.V.
- Roche Molecular Systems, Inc.
- Analytik Jena AG
- Thermofisher Scientific
- Accubiomed Co., Ltd.
- Autogen Inc.
- DiagCor Bioscience Inc Lt
- Taigen Bioscience Corporation
- Bioneer Corporation
Key Segments
By Type:
- Instruments
- Kits and consumables
By End Use:
- Hospitals
- Diagnostic Centres
- Forensic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific
- Japan
- Middle East and Africa
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
